IRadimed Corporation provided earnings guidance for the third quarter of 2022. For the quarter, the company expects to report revenue of $13.1 million to $13.3 million, GAAP diluted earnings per share of $0.21 to $0.24.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.43 USD | -1.65% | -2.55% | -10.62% |
05-02 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.62% | 546M | |
+75.71% | 12.56B | |
-23.93% | 7.47B | |
+8.28% | 6.75B | |
+11.63% | 5.5B | |
-16.58% | 4.94B | |
+29.47% | 4.66B | |
-25.47% | 3.75B | |
-23.06% | 2.92B | |
-2.23% | 1.98B |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- Iradimed Corporation Provides Earnings Guidance for the Third Quarter of 2022